Combining virtual screening and in vitro evaluation for the discovery of potential CYP11B2 inhibitors - Supporting Information

  

Fig.S1 RMSD of complexes CYP11B2 docking with 9 compounds / Fadrozole for 100ns simulations

  

Fig.S2 Contributions of free energy calculated by MM/GBSA for key residues of CYP11B2

  

Table S1 Pharmaceutical Properties of Compounds (Lipinski's Five Principles and Number of Rotatable Ronds)